Brazil
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
1.81
|
Dec. 31, 2023 | USD 0.31 | -1.64% |
|
Brazil |
|
2 |
1.68
|
Dec. 31, 2023 | USD 4.80 | 0.53% |
|
Brazil |
|
3 |
1.43
|
Dec. 31, 2023 | USD 1.95 | -3.23% |
|
Brazil |
|
4 |
1.26
|
Dec. 31, 2023 | USD 1.66 | 0.01% |
|
Brazil |
|
5 |
0.83
|
Dec. 31, 2023 | USD 2.04 | 0.87% |
|
Brazil |
|
6 |
0.74
|
Dec. 31, 2023 | USD 16.15 | -4.10% |
|
Brazil |
|
7 |
0.30
|
Dec. 31, 2023 | USD 2.21 | -0.40% |
|
Brazil |
|
8 |
0.14
|
Dec. 31, 2023 | USD 1.97 | 2.04% |
|
Brazil |
The Biotechnology company in Brazil with the highest Debt to Equity Ratio is Diagnósticos da América S.A. (São Paulo Stock Exchange: DASA3.SA) at 1.81.
The Biotechnology company in Brazil with the lowest Debt to Equity Ratio is Baumer S.A. (São Paulo Stock Exchange: BALM4.SA) at 0.14.
The top 10 Biotechnology companies in Brazil by Debt to Equity Ratio are Diagnósticos da América S.A., Rede D'Or São Luiz S.A., Centro de Imagem Diagnósticos S.A., Biomm S.A., Fleury S.A., Afya Limited, Blau Farmacêutica S.A. and Baumer S.A..
The bottom 10 Biotechnology companies in Brazil by Debt to Equity Ratio are Baumer S.A., Blau Farmacêutica S.A., Afya Limited, Fleury S.A., Biomm S.A., Centro de Imagem Diagnósticos S.A., Rede D'Or São Luiz S.A. and Diagnósticos da América S.A..